FLIP anticorps (AA 100-251)
Aperçu rapide pour FLIP anticorps (AA 100-251) (ABIN1845710)
Antigène
Voir toutes FLIP (CFLAR) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 100-251
-
Purification
- Purified antibody
-
Immunogène
- Purified recombinant fragment of human CFLAR (AA: 100-251) expressed in E. coli.
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS with 0.05 % sodium azide and 0.5 % protein stabilizer.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
-
-
- FLIP (CFLAR) (CASP8 and FADD-Like Apoptosis Regulator (CFLAR))
-
Autre désignation
- CFLAR
-
Sujet
- The protein encoded by this gene is a regulator of apoptosis and is structurally similar to caspase-8.However, the encoded protein lacks caspase activity and appears to be itself cleaved into two peptides by caspase-8.Several transcript variants encoding different isoforms have been found for this gene, and partial evidence for several more variants exists.
-
Poids moléculaire
- 55 kDa
-
ID gène
- 8837
-
Pathways
- Apoptose, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
Antigène
-